We will be leveraging Aptars experts to fast track FDA approval. From the article;
”Aptar’s dedicated Regulatory Affairs experts and analytical scientists help customers proactively address regulatory needs to help accelerate approval”
The drug Spontan delivers is already FDA approved…the delivery mechanism is not, but Aptar whose system we will be using have already been before FDA with neffy for their nasal system. FDA approval could happen a lot quicker than anticipated.
We will be leveraging Aptars experts to fast track FDA approval....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.020(7.14%) |
Mkt cap ! $33.58M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.0¢ | 28.5¢ | $77.51K | 265.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19787 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 10278 | 2 |
View Market Depth
| Last trade - 12.34pm 20/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |